This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Day Three Labs Manufacturing Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Adi Lahiani Hafzadi: Innovator in Protein-Based Cannabis Compositions
Introduction
Adi Lahiani Hafzadi is an inventive mind based in Jerusalem, Israel. He has made significant contributions to the field of cannabis research, particularly through his innovative patent related to protein-based cannabis compositions. His work reflects a growing interest in the intersection of nutrition and cannabis, paving the way for new applications in health and wellness.
Latest Patents
Adi holds a patent for a novel composition that includes a component selected from cannabinoids, flavonoids, and terpenoids, combined with proteins such as whey or various plant proteins. This innovative approach allows for the non-covalent binding of these components, enhancing the potential benefits of cannabis products. The plant proteins he considers include soy, pea, rice, hemp, and hops proteins, showcasing a diverse range of options for formulation.
Career Highlights
Adi is currently associated with Day Three Labs Manufacturing Inc., where he continues to explore and develop his ideas in cannabis formulations. His work is characterized by a commitment to advancing the understanding of how protein can interact with cannabis compounds to create beneficial health products.
Collaborations
Adi collaborates with talented individuals in his field, including Shimon Lecht and Olga Gabay. Their combined expertise contributes to the innovative environment at Day Three Labs Manufacturing Inc., fostering creativity and progress in cannabis research.
Conclusion
Adi Lahiani Hafzadi stands out as a pioneering inventor in the realm of protein-based cannabis compositions. His contributions are shaping the future of cannabis applications, emphasizing the importance of protein in enhancing the efficacy of these compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile